Home - Products - Microbiology/Virology - HCV - VCH-916 free acid(1200133-34-1 free base)

VCH-916 free acid(1200133-34-1 free base)

CAS No. 914778-92-0

VCH-916 free acid(1200133-34-1 free base)( —— )

Catalog No. M24958 CAS No. 914778-92-0

VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 87 In Stock
2MG 56 In Stock
5MG 82 In Stock
10MG 113 In Stock
25MG 202 In Stock
50MG 324 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VCH-916 free acid(1200133-34-1 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
  • Description
    VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV NS5B polymerase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    914778-92-0
  • Formula Weight
    459.64
  • Molecular Formula
    C26H37NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:39 mg/mL (78.36 mM)
  • SMILES
    O=C(C1=C(N([C@H]2CC[C@H](OC)CC2)C([C@H]3CC[C@H](C)CC3)=O)C=C(C4=CCCCC4)S1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ludmila Gerber, Tania M. Welzel, Stefan Zeuzem. New therapeutic strategies in HCV: polymerase inhibitors. Liver International. 2013,33(s1): 85-92
molnova catalog
related products
  • MK-8325

    MK-8325 is a potent, selective pan-genotype HCV NS5A inhibitor with IC50 of 15, 1 and 3 pM for GT1a, GT1b and GT2a, respectively.

  • U18666A

    U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.

  • ABT-072

    ABT-072 is a novel, orally bioavailable non-nucleoside HCV NS5B polymerase inhibitor with EC50 of 0.3 nM (GT1b).